MiMedx Receives Notice of Filing Delinquency from NASDAQ

MARIETTA, Ga., March 2, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today received written notification from the NASDAQ Stock Market that the Company is no longer in compliance with the NASDAQ Listing...